{"id":3076,"date":"2016-05-05T20:16:21","date_gmt":"2016-05-05T20:16:21","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=7016"},"modified":"2016-05-05T20:16:21","modified_gmt":"2016-05-05T20:16:21","slug":"medical-marijuana-inc-s-hempmeds-brasil-product-rsho-approved-by-brazilian-government-for-fourth-indication-as-a-prescription-for-import-cancer","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2016\/05\/05\/medical-marijuana-inc-s-hempmeds-brasil-product-rsho-approved-by-brazilian-government-for-fourth-indication-as-a-prescription-for-import-cancer\/","title":{"rendered":"Medical Marijuana, Inc.\u2019s HempMeds Brasil\u2122 Product RSHO\u2122 Approved by Brazilian Government for Fourth Indication as a Prescription for Import: Cancer"},"content":{"rendered":"

Legal<\/em> Notice: Due to current United States government regulations, Medical Marijuana, Inc. does not make any medical claims about their products, nor are any approved for the treatment of any medical indications.<\/em><\/p>\n

SAN<\/strong> DIEGO, May 5, 2016 <\/strong>\u2014 Medical Marijuana, Inc. <\/a>(OTC Pink: MJNA) is proud to announce to shareholders and the public that the Brazilian government has approved its hemp cannabidiol (CBD) oil<\/a> product Real Scientific Hemp Oil\u2122 (RSHO\u2122)<\/a> from HempMeds Brasil<\/a>\u2122 for a fourth indication for import as a prescription medication for the treatment of cancer.<\/p>\n

The first three indications approved for\u00a0HempMeds Brasil<\/a>\u2122 to import are: epilepsy<\/a>, Parkinson\u2019s <\/a> disease <\/a>and chronic pain<\/a>.<\/p>\n

\u201cWe are right now tempering our excitement because this is a process and it needs to be approached carefully and scientifically,\u201d states Dr. Stuart Titus<\/a>, CEO of Medical Marijuana, Inc. \u201cThe opportunity within Brazil may open doors for the Company to explore our RSHO\u2122 product as an adjunctive, potentially post-chemotherapy prescription medication, by assisting patients with their recovery.<\/p>\n

Further, this may even allow us to enter into pre-clinical work to see if there may be merit for botanical cannabis and its derivatives as a primary treatment option for certain types of cancers in those places in our world that may allow such alternative and integrative treatment options.”<\/p>\n

Dr. Titus continues: \u201cEvery country operates under different laws and regulations. In Brazil, although not a clinically tested medication that has been approved for this purpose, patients and their doctors may access any product around the globe that may show benefit for that patient’s condition. So far, our products have fallen into this category within Brazil with now four potential indications for doctors to write prescriptions.<\/p>\n

\u201cIn the United States, we make zero product claims and have sold our products as food supplements or dietary supplements. We do believe that plant-based cannabinoids may well supplement the functioning of the largest self-regulatory system within the human body — and with that, may come health and wellness benefits.<\/p>\n

\u201cWhile our company works toward the necessary studies to demonstrate to the medical community the potential benefits of botanical cannabis and its derivatives, many of our product users report anecdotal stories that are leading us toward our research goals. We thank and appreciate those who have contributed with their reports on user experience.”<\/p>\n

A recent Newsweek article, \u201cMarijuana Is a Wonder Drug When It Comes to the Horrors of Chemo,\u201d<\/a> references doctors recommending botanical cannabis for post-chemo patients who suffer from as many as 6 medical indications: nausea, vomiting, sleep, loss of appetite, pain, depression.<\/p>\n

Additional cancer information:<\/p>\n

Facts about cancer in the U.S. from the NIH \u2013 National Cancer Institute<\/a>:<\/p>\n